205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.23%
Revenue growth above 1.5x NXPI's 2.39%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
5.71%
Gross profit growth similar to NXPI's 5.20%. Walter Schloss would assume both firms track common industry trends.
0.51%
EBIT growth below 50% of NXPI's 6.26%. Michael Burry would suspect deeper competitive or cost structure issues.
6.95%
Operating income growth 1.25-1.5x NXPI's 6.26%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
3.85%
Net income growth under 50% of NXPI's 14.24%. Michael Burry would suspect the firm is falling well behind a key competitor.
3.83%
EPS growth under 50% of NXPI's 15.45%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
3.89%
Diluted EPS growth under 50% of NXPI's 20.19%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.33%
Slight or no buybacks while NXPI is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.32%
Slight or no buyback while NXPI is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-0.01%
Dividend reduction while NXPI stands at 1.08%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-12.94%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-19.39%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
60.04%
10Y revenue/share CAGR at 50-75% of NXPI's 114.06%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
55.67%
5Y revenue/share CAGR 1.25-1.5x NXPI's 42.17%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
20.69%
3Y revenue/share CAGR at 50-75% of NXPI's 40.09%. Martin Whitman would question if the firm lags behind competitor innovations.
353.80%
10Y OCF/share CAGR under 50% of NXPI's 4980.45%. Michael Burry would worry about a persistent underperformance in cash creation.
269.23%
5Y OCF/share CAGR above 1.5x NXPI's 117.78%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
77.37%
3Y OCF/share CAGR above 1.5x NXPI's 46.20%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
233.16%
Net income/share CAGR above 1.5x NXPI's 70.32% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
169.17%
5Y net income/share CAGR at 75-90% of NXPI's 209.24%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
36.82%
Below 50% of NXPI's 653.66%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
21.69%
Below 50% of NXPI's 562.38%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
13.46%
Positive 5Y equity/share CAGR while NXPI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
1.85%
Positive short-term equity growth while NXPI is negative. John Neff sees a strong advantage in near-term net worth buildup.
677.64%
Dividend/share CAGR of 677.64% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
167.94%
Dividend/share CAGR of 167.94% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
64.02%
3Y dividend/share CAGR of 64.02% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
12.02%
AR growth well above NXPI's 8.89%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.32%
Inventory is declining while NXPI stands at 2.52%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.49%
Positive asset growth while NXPI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
10.30%
Positive BV/share change while NXPI is negative. John Neff sees a clear edge over a competitor losing equity.
-12.21%
We’re deleveraging while NXPI stands at 0.03%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-0.52%
Our R&D shrinks while NXPI invests at 0.22%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
6.78%
SG&A growth well above NXPI's 0.45%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.